These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36249759)

  • 41. Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network.
    Heard JM; Vrinten C; Schlander M; Bellettato CM; van Lingen C; Scarpa M;
    Orphanet J Rare Dis; 2020 Jan; 15(1):3. PubMed ID: 31907071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [FINANCING OF MEDICINES FOR TREATMENT OF RARE DISEASES OF THE NERVOUS SYSTEM. ORPHAN DRUGS IN RARE NEUROLOGICAL DISEASES].
    Szegedi Márta ; Kosztolányi G; Boncz I; Molnár MJ
    Ideggyogy Sz; 2016 Jan; 69(1-2):37-45. PubMed ID: 26987239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing access to orphan medicinal products in Europe.
    Zamora B; Maignen F; O'Neill P; Mestre-Ferrandiz J; Garau M
    Orphanet J Rare Dis; 2019 May; 14(1):95. PubMed ID: 31053154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profile of Drug Utilization in Patients with Rare Diseases in Tuscany, Italy: A Population-Based Study.
    Gorini F; Santoro M; Pierini A; Mezzasalma L; Baldacci S; Coi A
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China.
    Liu P; Gong M; Li J; Baynam G; Zhu W; Zhu Y; Chen L; Gu W; Zhang S
    Front Pharmacol; 2021; 12():719415. PubMed ID: 34721018
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.
    Crisafulli S; Sultana J; Ingrasciotta Y; Addis A; Cananzi P; Cavagna L; Conter V; D'Angelo G; Ferrajolo C; Mantovani L; Pastorello M; Scondotto S; Trifirò G
    Expert Opin Drug Saf; 2019 Jun; 18(6):497-509. PubMed ID: 31059293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ORPHAcodes use for the coding of rare diseases: comparison of the accuracy and cross country comparability.
    Mazzucato M; Pozza LVD; Facchin P; Angin C; Agius F; Cavero-Carbonell C; Corrochano V; Hanusova K; Kirch K; Lambert D; Lucano C; Maiella S; Panzaru M; Rusu C; Weber S; Zurriaga O; Zvolsky M; Rath A
    Orphanet J Rare Dis; 2023 Sep; 18(1):267. PubMed ID: 37667299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of COMPASS: clinical evidence of orphan medicinal products - an assessment tool.
    Picavet E; Cassiman D; Aertgeerts B; Simoens S
    Orphanet J Rare Dis; 2013 Oct; 8():157. PubMed ID: 24107467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.].
    Crisafulli S; Trifirò G
    Recenti Prog Med; 2022; 113(7):425-429. PubMed ID: 35852077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.
    Kinsner-Ovaskainen A; Lanzoni M; Garne E; Loane M; Morris J; Neville A; Nicholl C; Rankin J; Rissmann A; Tucker D; Martin S
    Eur J Med Genet; 2018 Sep; 61(9):513-517. PubMed ID: 29597096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries.
    Morel T; Arickx F; Befrits G; Siviero P; van der Meijden C; Xoxi E; Simoens S
    Orphanet J Rare Dis; 2013 Dec; 8():198. PubMed ID: 24365263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lessons from the Rare Diseases Registry and Analytics Platform framework for development of a national rare diseases registry for India.
    Chaube P; Lankapalli A; Choudhury MC
    J Biosci; 2024; 49():. PubMed ID: 38383976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pediatric Orphan Drug Indications: 2010-2018.
    Kimmel L; Conti RM; Volerman A; Chua KP
    Pediatrics; 2020 Apr; 145(4):. PubMed ID: 32127360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?
    Rodriguez-Monguio R; Spargo T; Seoane-Vazquez E
    Orphanet J Rare Dis; 2017 Jan; 12(1):1. PubMed ID: 28057032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries.
    Nicod E; Annemans L; Bucsics A; Lee A; Upadhyaya S; Facey K
    Health Policy; 2019 Feb; 123(2):140-151. PubMed ID: 28400128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical assessment of belgian reimbursement dossiers of orphan drugs.
    Denis A; Mergaert L; Fostier C; Cleemput I; Hulstaert F; Simoens S
    Pharmacoeconomics; 2011 Oct; 29(10):883-93. PubMed ID: 21905759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Occurrence of 275 Rare Diseases and 47 Rare Disease Groups in Italy. Results from the National Registry of Rare Diseases.
    Taruscio D; Vittozzi L; Rocchetti A; Torreri P; Ferrari L
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 30002291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.